RNA Competitors & Alternatives

Compare Atrium Therapeutics, Inc. Common Stock with similar stocks in the same industry

Biotechnology

RNA

Main Stock
$12.90
Tradestie Score
59
Market Cap
$6.27B
Revenue Growth
-0.7%
Analyst Upside
+93.8%

Top Competitors

229 stocks in Biotechnology
Company Price Market Cap P/E Score Action
VOR Vor Biopharma Inc. Common Stock
$14.16
$269.08M - 50 Compare
KYTX Kyverna Therapeutics, Inc. Common Stock
$8.43
$258.18M - 54 Compare
VTYX Ventyx Biosciences, Inc. Common Stock
$14.00
$256.71M - 53 Compare
CABA Cabaletta Bio, Inc. Common Stock
$3.22
$211.28M - 54 Compare
SLS SELLAS Life Sciences Group, Inc. Common Stock
$7.21
$211.22M - 63 Compare
ACRS Aclaris Therapeutics, Inc.
$4.46
$202.58M - 52 Compare
CBIO Crescent Biopharma, Inc. Common Stock
$17.89
$199.71M - 51 Compare
FBRX Forte Biosciences, Inc. Common Stock
$20.83
$180.53M - 42 Compare
AVTX Avalo Therapeutics, Inc. Common Stock
$16.09
$170.45M - 49 Compare
ACHV Achieve Life Sciences, Inc.
$4.69
$158.43M - 62 Compare

Data updated: May 18, 2026 | Industry: Biotechnology (SIC 2834)

229 stocks in this industry